Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Short Interest Up 55.1% in January

Posted by Anthony Miller on Feb 16th, 2026

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report) saw a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 13,527 shares, an increase of 55.1% from the January 15th total of 8,723 shares. Currently, 1.5% of the company’s shares are short sold. Based on an average trading volume of 20,855 shares, the days-to-cover ratio is currently 0.6 days. Based on an average trading volume of 20,855 shares, the days-to-cover ratio is currently 0.6 days. Currently, 1.5% of the company’s shares are short sold.

Virtus LifeSci Biotech Clinical Trials ETF Trading Down 1.1%

BBC traded down $0.43 during mid-day trading on Monday, hitting $39.87. The stock had a trading volume of 13,941 shares, compared to its average volume of 26,768. The stock’s fifty day simple moving average is $40.17 and its 200-day simple moving average is $32.26. Virtus LifeSci Biotech Clinical Trials ETF has a 1-year low of $13.42 and a 1-year high of $44.10.

About Virtus LifeSci Biotech Clinical Trials ETF

(Get Free Report)

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.